The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-4-(2-Carboxy-4-oxoazetidine-1-carboxamidomethyl)-benzenaminium 2,2,2-trifluoroacetate ID: ALA4777693
PubChem CID: 162644198
Max Phase: Preclinical
Molecular Formula: C14H14F3N3O6
Molecular Weight: 263.25
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Nc1ccc(CNC(=O)N2C(=O)C[C@H]2C(=O)O)cc1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C12H13N3O4.C2HF3O2/c13-8-3-1-7(2-4-8)6-14-12(19)15-9(11(17)18)5-10(15)16;3-2(4,5)1(6)7/h1-4,9H,5-6,13H2,(H,14,19)(H,17,18);(H,6,7)/t9-;/m0./s1
Standard InChI Key: PBDSUCKUKNOMFW-FVGYRXGTSA-N
Molfile:
RDKit 2D
26 26 0 0 0 0 0 0 0 0999 V2000
5.6006 -8.0522 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.0134 -8.7621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4218 -8.0497 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.3076 -9.1748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7230 -9.1748 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.5973 -8.7725 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3122 -9.9949 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.3454 -9.8971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3454 -10.7143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1626 -10.7143 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1626 -9.8971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7676 -11.2921 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7405 -11.2921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5290 -12.0814 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5298 -11.0806 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7405 -9.3192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5322 -9.5275 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5314 -8.5266 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1077 -11.6584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8970 -11.4469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4707 -12.0275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2594 -11.8165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4715 -11.0264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8888 -10.4474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1023 -10.6614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2606 -10.8139 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 2 1 0
2 5 1 0
4 6 1 0
4 7 2 0
8 9 1 0
9 10 1 0
10 11 1 0
11 8 1 0
9 12 2 0
10 13 1 0
13 14 2 0
13 15 1 0
11 16 1 1
16 17 1 0
16 18 2 0
15 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
23 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 263.25Molecular Weight (Monoisotopic): 263.0906AlogP: 0.16#Rotatable Bonds: 3Polar Surface Area: 112.73Molecular Species: ACIDHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.54CX Basic pKa: 4.28CX LogP: -1.26CX LogD: -3.71Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.53Np Likeness Score: -0.50
References 1. Baiula M,Galletti P,Martelli G,Soldati R,Belvisi L,Civera M,Dattoli SD,Spampinato SM,Giacomini D. (2016) New β-Lactam Derivatives Modulate Cell Adhesion and Signaling Mediated by RGD-Binding and Leukocyte Integrins., 59 (21): [PMID:27726366 ] [10.1021/acs.jmedchem.6b00576 ]